Founded in 2014, Genezen Laboratories is focused on supporting the demands of the current and future gene and cell therapy manufacturing market—making viral vector production accessible to both early-stage, growth-oriented companies and well-established industry leaders. The Genezen mission of gene and cell therapy acceleration is the outcome of expansive knowledge and experience in the industry and working with the nation’s leading institutions and therapeutic companies. Genezen’s available capacity and expert viral vector production services will advance your gene or cell therapy project efficiently to the clinic.
Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services by leveraging inhouse capacity combined with the expertise of the nation’s leading academic vector production and research laboratories. Our experienced, connected team of professionals is prepared to develop a tailored process to best meet your needs at any stage. Genezen’s 25,000 sq. ft. facility is located in the Midwest with logistics accessibility and designed to accommodate clinical drug development activities from process development to GMP manufacturing and product release. Our developed solutions provide the right expertise, capacity, and technology to bring breakthrough treatments to market.